Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
Among all malignant tumors, lung cancer has the highest mortality and morbidity rates. The non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the most common histological subtypes. Although there are a number of internationally recognized lung cancer therapy regimens, their the...
Saved in:
Main Authors: | Yishi Xu (Author), Yaqing Liu (Author), Yi Ge (Author), Haozhe Li (Author), Yi Zhang (Author), Liping Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies
by: Neha Thakur, et al.
Published: (2024) -
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
by: Xia Zhou, et al.
Published: (2023) -
Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
by: Wujian Zheng, et al.
Published: (2017) -
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
by: Xin Zhang, et al.
Published: (2023) -
Editorial: New strategies for reversing cancer therapy resistance
by: Yue Du, et al.
Published: (2024)